4-溴-2-氟-1-正丙氧基苯 | 127326-77-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 中文名称: 4-溴-2-氟-1-正丙氧基苯
• 中文别名: 4-溴-2-氟-1-丙氧基苯
• 英文名称: 4-bromo-1-propoxy-2-fluorobenzene
• 英文别名: 4-Bromo-2-fluoro-1-propoxybenzene
• CAS: 127326-77-6
• 化学式: C₉H₁₀BrFO
• 分子量: 233.08
• InChiKey: MHEJXUAOBZGJKW-UHFFFAOYSA-N

物化性质

• 沸点：
  251.5±20.0 °C(Predicted)
• 密度：
  1.396±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.6
• 重原子数：
  12
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  9.2
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• 海关编码：
  2909309090

反应信息

• 作为反应物：
  描述：

  4-溴-2-氟-1-正丙氧基苯 在 双氧水 、 lithium diisopropyl amide 作用下， 以 四氢呋喃 为溶剂， 反应 5.0h， 生成 6-Bromo-2-fluoro-3-propoxyphenol
  参考文献：
  名称：

  一种负介电各向异性的液晶化合物及其制备 方法与应用

  摘要：

  本发明涉及液晶领域，具体涉及一种新型二苯并呋喃类负介电各向异性化合物及其制备方法与应用，所述液晶化合物具有通式(I)所示的结构，其中，R表示具有1‑12个碳原子的烷基或烷氧基。本发明所提供的液晶化合物，化学主体结构为二苯并呋喃，此类结构本身介电各向异性较大，本发明所提供的液晶化合物具有极高的负介电各向异性、更高的清亮点、相对更低的旋转粘度以及良好的液晶互溶性等优点。使用了所述液晶化合物的组合物能够有效降低驱动电压，提高了液晶显示装置的响应速度，同时具有光学各向异性数值适中、电荷保持率高等特点。

  公开号：

  CN109207160B

文献信息

• Compounds
  申请人：Astra Pharmaeuticals Ltd.

  公开号：US05977105A1

  公开（公告）日：1999-11-02

  A compound of formula I, ##STR1## wherein--X represents (CH.sub.2).sub.n O, (CH.sub.2).sub.n S or C.sub.2 alkylene; n represents 1 or 2; Ar.sup.1 represents indanyl, tetrahydronaphthyl, naphthyl or phenyl, which latter two groups may be substituted by one or more substituents selected from chloro, fluoro, OR.sup.1, O(CH.sub.2).sub.m CONR.sup.20 R.sup.21, C(O)R.sup.2, C.sub.1-6 alkyl (optionally substituted by one or more fluorine atoms), pyridyl, thiazinyl, phenyl or C.sub.7-9 alkylphenyl which latter two groups are optionally substituted by one or more substituent selected from halo, nitro, OR.sup.3, C.sub.1-6 alkyl (optionally substituted by one or more fluorine atoms), C(O)R.sup.4, C(O)OR.sup.5, C(O)N(R.sup.6)R.sup.7, CN, CH.sub.2 OR.sup.14, CH.sub.2 NR.sup.15 R.sup.16, N(R.sup.8)R.sup.9, N(R.sup.10)SO.sub.2 R.sup.11, N(R.sup.12)C(O)R.sup.13, OC(O)R.sup.19 and SO.sub.2 NR.sup.17 R.sup.18 ; m represents an integer 1 to 3; R.sup.1, R.sup.2 and R.sup.3 independently represent H, C.sub.1-10 alkyl (optionally substituted by one or more fluorine atoms), C.sub.7-9 alkylphenyl or phenyl, which latter group is optionally substituted by hydroxy; and R.sup.4, R.sup.5, R.sup.6, R.sup.7, R.sup.8, R.sup.9, R.sup.10, R.sup.11, R.sup.12, R.sup.13, R.sup.14, R.sup.15, R.sup.16, R.sup.17, R.sup.18, R.sup.19, R.sup.20 and R.sup.21 independently represent H, C.sub.1-6 alkyl (optionally substituted by one or more fluorine atoms) or phenyl; in which any alkyl group present may be interrupted by one or more oxygen atoms; provided that when X represents CH.sub.2 CH.sub.2, Ar.sup.1 may not represent phenyl or phenyl substituted with one or more substituents OR.sup.1, in which R.sup.1 represents C.sub.1-10 alkyl; or a pharmaceutically acceptable derivative thereof, may be used for the treatment of a reversible obstructive airways disease or allergic conditions of the skin, nose and eye.

  一种具有以下结构式I的化合物，其中--X代表(CH₂)ₙO，(CH₂)ₙS或C₂烷基；n代表1或2；Ar¹代表茚基、四氢萘基、萘基或苯基，后两种基团可以被来自氯、氟、OR¹、O(CH₂)ₘCONR²⁰R²¹、C(O)R²、C₁-₆烷基（可选地被一个或多个氟原子取代）、吡啶基、噻唑基、苯基或C₇-₉烷基苯基的一个或多个取代基所取代；后两种基团可以被来自卤素、硝基、OR³、C₁-₆烷基（可选地被一个或多个氟原子取代）、C(O)R⁴、C(O)OR⁵、C(O)N(R⁶)R⁷、CN、CH₂OR¹⁴、CH₂NR¹⁵R¹⁶、N(R⁸)R⁹、N(R¹⁰)SO₂R¹¹、N(R¹²)C(O)R¹³、OC(O)R¹⁹和SO₂NR¹⁷R¹⁸所选取的一个或多个取代基所取代；m代表整数1到3；R¹、R²和R³独立地代表H、C₁-₁₀烷基（可选地被一个或多个氟原子取代）、C₇-₉烷基苯基或苯基，后一基团可选地被羟基取代；R⁴、R⁵、R⁶、R⁷、R⁸、R⁹、R¹⁰、R¹¹、R¹²、R¹³、R¹⁴、R¹⁵、R¹⁶、R¹⁷、R¹⁸、R¹⁹、R²⁰和R²¹独立地代表H、C₁-₆烷基（可选地被一个或多个氟原子取代）或苯基；其中任何存在的烷基基团可以被一个或多个氧原子中断；但是当X代表CH₂CH₂时，Ar¹不能代表苯基或被一个或多个取代基OR¹取代的苯基，其中R¹代表C₁-₁₀烷基；或其药学上可接受的衍生物，可用于治疗可逆性阻塞性气道疾病或皮肤、鼻子和眼睛的过敏症状。
• [EN] INHIBITORS OF HEPATITIS C VIRUS RNA-DEPENDENT RNA POLYMERASE, AND COMPOSITIONS AND TREATMENTS USING THE SAME<br/>[FR] INHIBITEURS DE L'ARN POLYMERASE ARN-DEPENDANTE DU VIRUS DE L'HEPATITE C ET COMPOSITIONS ET TRAITEMENTS UTILISANT CETTE POLYMERASE
  申请人：PFIZER

  公开号：WO2003095441A1

  公开（公告）日：2003-11-20

  Compounds of formula (I) are hepatitis C virus (HCV) RNA-dependent RNA polymerase (RdRp) inhibitors, and are useful in therapeutic and prophylactic treatment of persons infected with hepatitis C virus.

  化合物的化学式（I）是丙型肝炎病毒（HCV）RNA依赖性RNA聚合酶（RdRp）抑制剂，对感染丙型肝炎病毒的人进行治疗和预防性治疗具有用处。
• 3,3′-difluorobiphenyl derivatives, liquid crystal compositions, and liquid crystal display elements
  申请人：Chisso Corporation

  公开号：US06197217B1

  公开（公告）日：2001-03-06

  Liquid crystalline compounds which exhibit a negative dielectric anisotropy value, have an extremely high voltage holding ratio and a low threshold voltage, are small in their dependency on temperature, hardly exhibit smectic phase, and are excellent in miscibility with other liquid crystal materials at the same time; liquid crystal compositions comprising the compound; and liquid crystal display devices fabricated by using the liquid crystal composition are provided; the liquid crystalline compounds being specific 3,3′-difluorobiphenyl derivatives expressed by the following general formula (1):

  提供具有负电介质各向异性值的液晶化合物，具有极高的电压保持比和低的阈值电压，对温度的依赖性小，几乎不表现出液晶相，同时与其他液晶材料混合优秀的液晶组合物；液晶组合物包括该化合物；以及通过使用该液晶组合物制造的液晶显示装置。该液晶化合物为以下通式（1）所表示的特定3,3'-二氟联苯衍生物。
• POLYMERIZABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL DISPLAYS
  申请人：MERCK PATENT GMBH

  公开号：US20140375943A1

  公开（公告）日：2014-12-25

  The present invention relates to polymerizable compounds, to processes and intermediates for the preparation thereof, to liquid-crystal (LC) media comprising them, and to the use of the polymerizable compounds and LC media for optical, electro-optical and electronic purposes, in particular in LC displays, especially in LC displays of the PSA (“polymer sustained alignment”) type.

  本发明涉及可聚合化合物、其制备过程和中间体、包含它们的液晶（LC）介质，以及将可聚合化合物和LC介质用于光学、电光和电子目的的使用，特别是在LC显示器中，特别是在PSA（“聚合物持续定向”）类型的LC显示器中。
• 3,3'-DIFLUOROBIPHENYL DERIVATIVES, LIQUID CRYSTAL COMPOSITIONS, AND LIQUID CRYSTAL DISPLAY ELEMENTS
  申请人：CHISSO CORPORATION

  公开号：EP0959061A1

  公开（公告）日：1999-11-24

  Liquid crystalline compounds which exhibit a negative dielectric anisotropy value, have an extremely high voltage holding ratio and a low threshold voltage, are small in their dependency on temperature, hardly exhibit smectic phase, and are excellent in miscibility with other liquid crystal materials at the same time; liquid crystal compositions comprising the compound; and liquid crystal display devices fabricated by using the liquid crystal composition are provided; the liquid crystalline compounds being specific 3,3'-difluorobiphenyl derivatives expressed by the following general formula (1):

  本发明提供了具有负介电各向异性值、极高的电压保持率和较低的阈值电压、对温度的依赖性小、几乎不呈现共晶相、同时与其他液晶材料的混溶性极佳的液晶化合物；包含该化合物的液晶组合物；以及使用该液晶组合物制造的液晶显示设备；该液晶化合物是由以下通式（1）表示的特定 3,3'-二氟联苯衍生物：